financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Nurix Therapeutics Q1 Net Loss Narrows, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nurix Therapeutics Q1 Net Loss Narrows, Revenue Increases
Apr 8, 2025 1:35 PM

04:15 PM EDT, 04/08/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) reported a Q1 net loss Tuesday of $0.67 per diluted share, narrower than a loss of $0.76 a year ago.

Analysts polled by FactSet expected a loss of $0.78.

Revenue for the quarter ended Feb. 28 was $18.5 million, up from $16.6 million a year earlier.

Analysts surveyed by FactSet expected $13.9 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Mueller Water Products Increases Quarterly Dividend to $0.067 per Share From $0.064; Payable Nov. 20 to Shareholders of Record on Nov. 8
--Mueller Water Products Increases Quarterly Dividend to $0.067 per Share From $0.064; Payable Nov. 20 to Shareholders of Record on Nov. 8
Oct 23, 2024
04:03 AM EDT, 10/23/2024 (MT Newswires) -- Price: 22.01, Change: -0.06, Percent Change: -0.27 ...
 Synaptics Expands Taiwan Presence, Operations
Synaptics Expands Taiwan Presence, Operations
Oct 23, 2024
03:57 AM EDT, 10/23/2024 (MT Newswires) -- Synaptics ( SYNA ) said late Tuesday it has expanded in the Taiwanese city of Hsinchu, making Taiwan the company's largest base of personnel worldwide. The company said the expansion gives it headroom to grow both its essential operations and engineering expertise. The facilities will house the team developing its AI-enabled devices for...
 Finance guide could spur extra $200 billion for sustainable development, JPMorgan says
Finance guide could spur extra $200 billion for sustainable development, JPMorgan says
Oct 23, 2024
* Impact disclosure guidance released by Taskforce * Group chaired by JPMorgan ( JPM ), Natixis * Aims to help countries, companies raise impact finance By Karin Strohecker and Simon Jessop WASHINGTON, Oct 23 (Reuters) - A new guide for countries and companies seeking financing for activities that have a positive and verifiable social or environmental impact could unlock an...
 Alto Neuroscience Says Phase 2b Study in Major Depressive Disorder Fails to Meet Primary Endpoint
Alto Neuroscience Says Phase 2b Study in Major Depressive Disorder Fails to Meet Primary Endpoint
Oct 23, 2024
04:06 AM EDT, 10/23/2024 (MT Newswires) -- Alto Neuroscience ( ANRO ) said late Tuesday a phase 2b study of ALTO-100 in patients with major depressive disorder failed to meet its primary endpoint compared with placebo. Treatment with ALTO-100 did not demonstrate improvement in depressive symptoms compared to placebo in patients with a memory-based cognitive biomarker, Alto Neuroscience ( ANRO...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2025 - www.financetom.com All Rights Reserved